DEVICE FOR THE ADMINISTRATION OF DRUGS, PARTICULARLY TWO-COMPONENT DRUGS

Abstract: The device comprises a tubular housing (10) with two jackets (12, 13) and a container (30) filled with the liquid component of the drug. Within the inner jacket (13) of the housing (10), close to the closed end (11) thereof, is a chamber (120) containing the powdered components of the drug. A needle (20) for piercing the stopper (31) which closes the container (30) enables the interior of the container (30) to be put in communication with the said chamber (120) so as to allow the liquid component to flow out and consequently mix with the powdered component. The subsequent advance of the container (30) into the housing (10), with the consequent penetration of the piston (31) into the container (30), causes the further flow of the liquid component into the chamber (120) carrying the drug solution to the exterior (38) of the device generally like as syringe. Its use as a supplier of infusions is also foreseen.

Description: DEVICE FOR THE ADMINISTRATION OF DRUGS. PARTICULARLY TWO- COMPONENT DRUGS The present invention relates to devices for the administration of drugs. More particularly, the present invention constitutes an improvement in the solution described in the prior Italian Industrial utility model application 15156-B/89. The application in question relates to a device for the administration of drugs, particularly liquids, comprising a double-walled housing which is open at one end and closed at the other by an end wall, in which a needle is fixed and extends substantially the entire length of the housing. The inner jacket of the housing is threaded at least at its open end so as to receive a threaded spigot of a piston applied in the form of a stopper to the open end of a cylindrical container housing the liquid to be administered. The piston has an axial bore closed by a diaphragm which can be pierced by the needle when the spigot of the piston is screwed into the inner jacket. By forming the cylindrical container axially into the said housing it is possible to supply the said liquid product. The entirety is generally like a syringe; it is also possible to envisage the use of this same structure as a device for supplying infusions. The present invention attempts principly to improve on this prior solution so as to extend its use to the supply of drugs constituted by a liquid and a powder which must be dissolved in the liquid before use. At present the usual method used with drugs of this type provides for a liquid to be drawn up from a phial into a syringe and then for the liquid to be injected into another phial containing the powdered drug and then - after the drug has dissolved - for the solution to be taken up again in a syringe before the injection proper can be effected: a sequence of operations which is rather complicated and must be carried out with extreme care. According to the present invention, the object is achieved by means of a device for the administration of drugs having the characteristics claimed specifically in the claims which follow. The invention will now be described, purely by way of non-limiting example, with reference to the appended drawings, in which: - Figure 1 is an axial section through a housing of a device according ro rhe invention; - Figure 2 is an axial section through the container intended to house one of the components, typically the liquid vector of the drug to be supplied, Figure 3 shows one of the elements of the container of Figure l in greater clarity, and - Figure 4 shows the device of the invention in its condition of use. In its essentials and in its basic characteristics of use, the device of the invention does not differ substantially from the device which is the subject of the prior application 15156-B/89 to which reference has already been made. In particular, Figures 1 to 4 of τhe drawings appended hereto correspond to Figures 1 to 4 of the prior application and the same reference numerals are used to indicate identical or equivalent parts to those used in the specification of the prior application. Thus, reference 10 generally indicates a cylindrical housing having an end wall 11 and two concentric jackets 12 and 13 which define an annular chamber 14 and a central hollow body 15. Similarly a needle fixed within the inner jacket 13 of the body 10 is indicated 20. However the solution of the present invention differs from that described in application 15156-B/89 in that the needle 20 does not extend through the entire length of the housing 10, that is, from the end wall 11 up to the opposite, open end of the housing 10, but only through part of the length of the housing 10 itself: more precisely, it extends through that part which is between an intermediate partition 100 within the jacket 13 and the end o the jacket which is towards the open end of the housing 11. More particularly, one of the ends of the needle 20 passes through the partition 100 and defines an end chamber 120 within the inner jacket 13 which, in the embodiment illustrated here, occupies about a third of the overall length of the jacket 13 itself. Naturally, this dimensional choice, although preferred for several reasons, should certainly not be considered as limiting. The chamber 120 is intended to contain the powdered component of the two-component drug (liquid-powder) intended to be injected by the device of the invention. For the rest, in substantial analogy with the solution described in application 15156-B/89, the needle 20 terminates at its end opposite the chamber 120 in a pointed end 21 intended to pass through the perforable stopper 31 (illustrated in greater detail in Figure 3) of the cylindrical container 30 which houses the liquid component of the drug to be injected. Close to the open end of the housing 10, the needle 20 is supported by an intermediate diaphragm 22 beyond which the inner wall of the internal jacket 13 is threaded. The end of the outer jacket 12 has an external flange 16 intended to act as a hand grip for use of the device as a syringe. The container 30 is closed by a piston 31 which, in the original condition in which the container 1 is packaged, is arranged close to the end of the container itself. The piston has a threaded spigot 32 projecting from the container and adapted to be screwed into the threaded end of the inner jacket 13. The piston 31 and the spigot 32 are traversed by an axial bore 33 for receiving the end of the needle 20. In order to seal the container 30, the axial bore 33 is closed in an intermediate position by a diaphragm 34 intended to be pierced by the pointed end 21 of the needle 20. The piston 31, which acts as a stopper for the container 30, is held in a fixed position until the moment of use by a small disc 35 which acts as a stop seal and whose edges are bent over and clamped lightly against the outer surface of the drug container 30. The disc 35 has a central aperture for the sealed passage of the spigot 32. The turned edge of the disc 35 serves as a stop for the annular edge of a cup-shaped cap 36 which serves to protect the spigot 32 and to maintain sterility until the moment at which the drug 30 is supplied. In general, the housing 11 and the container 30 are supplied as components of a kit or equipment packaged under sterile conditions the administration of two- component drugs, a powdered component (contained in the chamber 120 in the inner jacket 13 of the housing 11) and a liquid component or vector disposed in the container 30, respectively. At the moment of use, the housing 11 and the container 30 are removed from the kit. After the protective cover 36 has been removed (with tearing of the disc 35) , the container 30 is engaged in the housing 10 by the screwing of the spigot 32 into the threaded portion of the inner jacket 13 until the condition illustrated in Figure 4 has been achieved. More particularly, the peripheral wall or skirt of the container 30, which has radial dimensions intermediate those of the two jackets 12 and 13, is inserted in the annular chamber 14. During the progressive screwing of the spigot 32, the needle 20 penetrates the axial bore 33 until it reaches the diaphragm 34. As the spigot 32 continues to be screwed in, the end 21 of the needle 20 pierces the diaphragm 34 and puts the interior of the container 30 into communication with the interior of the needle 20 and, through the latter, with the chamber 120. In these conditions, pressure on the container 30 so as to make it penetrate further into the annular chamber 14, causes the piston 31 to advance into the container 30 with the consequent pumping of the liquid drug component into the chamber 120 which contains the powdered component. When a sufficient quantity of liquid has been made to flow into the chamber 120, the powdered component of the drug can pass into solution, with a mixing process which can be facilitated by the agitation of the assembly formed by the housing 11 and the container 30 interconnected as shown in Figure 4. As already seen from the solution of application 15156- B/89, the end wall 11 of the housing 10 terminates with a spigot 38 in which, or around which, may be arranged the bush or ring nut of a hypodermic needle. When the hypodermic needle has been fitted onto the spigot 38 and the flanges 16 of the housing 10 are gripped with two fingers, pressure of the thumb on the base of the container 30 causes its further advance into the annular chamber 14 and the consequent, gradual and ■ complete penetration of the piston 31 into the container 30 itself. Thus the liquid component of the drug housed in the container 30 is expelled completely and, passing through the needle 20 into the chamber 120, takes the drug solutior: formed previously in this chamber with it and enables it to be carried to the exterior through the hypodermic needle mounted on the spigot 30. The two-component drug may thus be injected in the usual manner of use of a syringe. Naturally, the solution of the invention may also be used for supplying a tube for infusions. In this case, the housing 10 could usefully be provided with a lateral air take-off for enabling the slow emptying of the drug container 30. In the latter case the sealing disc 35 would not need to be removed and would ensure that the flow of liquid (and of the solution of the drug carried thereby) occurred solely under gravity by virtue of the presence of the aforesaid air take-off. Naturally, the scope of the present invention extends to models which achieve equal utility by the use of the same innovative concept.

Claims: CLAIMS 1. A device for the administration of drugs, comprising a tubular housing (10) and a container (30) intended to be coupled together in use, in which the housing (10) has a double wall with an outer jacket (12) and an inner jacket (13) and is open at one end and closed by an end wall (11) at the other end, a needle (20) being mounted in the inner casing (13) and extending such that its pointed end (21) is towards the open end of the housing (10) and in which the container (30) is provided with a stopper in the form of a slidable piston (31) intended to be coupled to the open end of the inner jacket (13) of the housing, the piston having an axial bore (33) intended to be perforated by the penetration of the needle (20) into the axial bore (33) thereof when the housing (10) and the container (30) are coupled together, characterised in that the container (30) is able to be filled with a liquid drug component and the inner jacket (13) of the housing includes a chamber (120) adjacent the end wall (11) into which the end of the needle (20) opposite the pointed end thereof opens, the chamber being able to receive a drug component intended to be dissolved in the liquid component, the arrangement being such that, when the housing (10) and the container (30) are coupled together, the interior of the container (30) is put into communication with the chamber (120) through the said axial bore (33) pierced by the needle (20) , whereby the liquid drug component can flow into the chamber (120) bringing the two drug components into contact with each other for their subsequent supply to the exterior (38) of the device. 2. A device according to Claim 1, characterised in that the chamber (120) is defined by the end wall (11) and by an intermediate partition (100) in the inner jacket (13) respectively. 3. A device according to Claim 2, characterised in that the intermediate partition (100) acts as a support for the needle (20) . 4. A device according to any one of the preceding Claims, characterised that the chamber (120) has a volume of about one third of the overall volume of the inner jacket (13). 5. A device according to any one of the preceding Claims, characterised in that the end wall (11) of the housing has means (38) for its connection to a hypodermic needle. 6. A device according to any one of Claims 1 to 5, characterised in that the piston (31) has a threaded spigot part (32) for screw coupling with the inner jacket (13) of the housing (10) . 7. A device according to Claim 6, characterised in that a sealing disc (35) is fixed to the spigot (32) for ensuring the sealing of the container (30) and for preventing the axial movement of the piston (31) relative to the container (30) before use. 8. A device according to any one of the preceding Claims, characterised in that the axial bore (33) is closed by a diaphragm (34) intended to be pierced by the needle (20) when the housing (10) and the container (30) are coupled together. 9. A device according to any one of the preceding Claims, characterised in that the container (30) has diametral dimensions such as to allow it to penetrate the annular space (14) between the outer jacket (12) and the inner jacket (13) of the housing. 10. A device for the administration of drugs, substantially as described and illustrated and for the purposes specified.

Inventors: ROLLANDI GIAN ANDREA, TOMELLINI GIORGIO, ROLLANDI, GIAN, ANDREA, TOMELLINI, GIORGIO
Applicants: TECNOMEDICA RICERCHE SRL, TECNOMEDICA RICERCHE S.R.L.
Application year: 1992
Main classification: A61M5
IPC codes: A61M5